Review: could Herceptin cause Peripheral sensory neuropathy?
We study 10,347 people who have side effects while taking Herceptin from FDA and social media. Among them, 15 have Peripheral sensory neuropathy. Find out below who they are, when they have Peripheral sensory neuropathy and more.
Stay connected: get help anytime and anywhere for people who take Herceptin and have Peripheral sensory neuropathy >>>
Herceptin (latest outcomes from 10,442 users) has active ingredients of trastuzumab. It is often used in breast cancer.
Peripheral sensory neuropathy
Peripheral sensory neuropathy (damage to one or more of your peripheral nerves) (latest reports from 10,989 patients) has been reported by people with multiple myeloma, breast cancer, rheumatoid arthritis, high blood pressure, osteoporosis.
On Jul, 13, 2014: 10,346 people reported to have side effects when taking Herceptin. Among them, 15 people (0.14%) have Peripheral Sensory Neuropathy. They amount to 0.14% of all the 10,969 people who have Peripheral Sensory Neuropathy on eHealthMe.
Time on Herceptin when people have Peripheral sensory neuropathy * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Peripheral sensory neuropathy||75.00%||12.50%||0.00%||12.50%||0.00%||0.00%||0.00% |
Gender of people who have Peripheral sensory neuropathy when taking Herceptin * :
|Peripheral sensory neuropathy||87.50%||12.50% |
Age of people who have Peripheral sensory neuropathy when taking Herceptin * :
|Peripheral sensory neuropathy||0.00%||0.00%||0.00%||0.00%||21.05%||21.05%||36.84%||21.05% |
Severity of Peripheral sensory neuropathy when taking Herceptin ** :
How people recovered from Peripheral sensory neuropathy ** :
Top conditions involved for these people * :
- Breast cancer (11 people, 73.33%)
- Breast cancer metastatic (5 people, 33.33%)
- Gastric cancer (2 people, 13.33%)
- Neoplasm malignant (1 people, 6.67%)
Top co-used drugs for these people * :
- Paclitaxel (12 people, 80.00%)
- Cyclophosphamide (7 people, 46.67%)
- Doxorubicin hcl (6 people, 40.00%)
- Tamoxifen citrate (4 people, 26.67%)
- Leucovorin calcium (3 people, 20.00%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Citations of the study:
You can also:
Comments from related studies:
From this study (7 months ago):
Post - chemo skin is heavily laden with blackheads, which were not present before or during chemo. Herceptin is still an active treatment.
From this study (9 months ago):
Very weak legs from dexamethasone, can't walk too much, and lower back pain
From this study (9 months ago):
Symptoms on Carpat tunnel syndrome started 6 months after treatment with Taxol was completed, but during the last 3 months of treatment with Herceptin.
Post a new comment OR Read more comments
Can you answer these questions (what is this?):
More questions for: Herceptin, Peripheral sensory neuropathy
More reviews for: Herceptin, Peripheral sensory neuropathy
On eHealthMe, Herceptin (trastuzumab) is often used for breast cancer. Find out below the conditions Herceptin is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions.
What is Herceptin used for and how effective is it:
Other drugs that are used to treat the same conditions:
Could it be a symptom from a condition:
Drugs in real world that are associated with:
Could your condition cause it?
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.